Abstract
Methotrexate has been used to treat patients with primary biliary cirrhosis as it possesses immunosuppressive properties. The previously prepared version of this review from 2005 showed that methotrexate seemed to significantly increase mortality in patients with primary biliary cirrhosis. Since that last review version, follow-up data of the included trials have been published.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Cochrane Database of Systematic Reviews |
Udgave nummer | 5 |
Sider (fra-til) | CD004385 |
ISSN | 1469-493X |
DOI | |
Status | Udgivet - 1 jan. 2010 |